Awards Nomination 20+ Million Readerbase
PMC/PubMed Indexed Articles

Development of Secreted Protein and Acidic and Rich in Cysteine (SPARC) Targeted Nanoparticles for the Prognostic Molecular Imaging of Metastatic Prostate Cancer

The Highs and Lows of FAIMS: Predictions and Future Trends for High Field Asymmetric Waveform Ion Mobility Spectrometry

View More »

Google Scholar citation report
Citations : 8261

Journal of Nanomedicine & Nanotechnology received 8261 citations as per Google Scholar report

Flyer image
Journal of Nanomedicine & Nanotechnology peer review process verified at publons
Flyer image
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • Scientific Indexing Services (SIS)
  • Euro Pub
  • Google Scholar
View More
Useful Links
Share This Page
Journal Flyer
Flyer image
Open Access Journals
View More

Khaled Greish

Khaled Greish

Khaled Greish Department of Pharmacology & Toxicology Otago School of Medical Sciences University of Otago New Zealand

Biography
Dr Greish graduated from the Faculty of Medicine, Suez Canal University, Egypt in 1992. He received his master degree of clinical oncology in 1997. Then he moved to Japan from 1999 to early 2008 to join the lab of Professor Hiroshi Maeda, a world leader in the field of anticancer Nanomedicine. Initially as a PhD student, then as JSPS post-doctoral fellow. Along with Professor Maeda they both developed an affordable platform Nanotechnology miceller system for targeting anticancer drugs specifically to solid tumours. In 2008 he moved to the United States to join the department of pharmaceutics and pharmaceutical chemistry department, University of Utah, as Research Assistant Professor. His contribution to the research field of anticancer drug delivery were recognized by the Controlled Release Society (CRS), by awarding him the CRS Postdoctoral Achievement award in 2008 and in 2010 by electing him as a CRC College of Fellows in 2010.
Research Interest
Dr Greish's areas of interest span the formulation and characterization of different advanced drug delivery systems, anticancer drug discovery/development, tumour vascular biology and animal tumour models.